GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 1996
    In:  Anesthesiology Vol. 84, No. 3 ( 1996-03-01), p. 596-604
    In: Anesthesiology, Ovid Technologies (Wolters Kluwer Health), Vol. 84, No. 3 ( 1996-03-01), p. 596-604
    Kurzfassung: The goal of this investigation was to characterize the effects of thiopental on cardia output and regional blood flows in the rat. Blood flows influence thiopental pharmacokinetics. Acquisition of these data may ultimately permit evaluation of the contribution of thiopental-induced alterations in regional blood flows to the disposition and hypnotic effect of this drug. Methods Chronically instrumented unrestrained Wistar rats (n=20) aged 3-4 months received either a dose of thiopental sufficient to induce a brief period of unconsciousness (20 mg.kg(-1)) or a larger dose achieving electroencephalographic burst suppression (45 mg.kg(-1)). Cardiac output and blood flows to 14 tissues were determined at 4 times in each rat for a period of 420 min using injections of radioactive microspheres (expressed as mean +/- SD). Mean arterial pressure, heart rate, and blood gas tensions were determined at all measurement times. Arterial plasma concentrations were sampled at postinfusion times. Results No important changes in systemic cardiovascular measurements were detected after the smaller dose of thiopental. One minute after the larger dose, cardiac output decreased from baseline (123 +/- 14 to 84 +/- ml.min (-1), P & lt; 0.01), flow to muscle and fat decreased, and muscle and fat resistance increased. At 5 min, compared to baseline, no difference in cardiac output was detected (123 +/- vs. 119 +/- ml.min (-1)), intestinal flows increased and intestinal resistances decreased. Cardiac output was again depressed at 30, 90, and 180 min. Brain blood flow decreased 25 +/- 19 % (P & lt; 0.01) from baseline for the duration of the study. Conclusions Thiopental acutely decreases cardiac output, and blood flows to muscle and fat tissue. The temporary return of cardiac output to baseline may be related to intestinal vasodilation. These blood flow alterations may influence the pharmacokinetics of thiopental.
    Materialart: Online-Ressource
    ISSN: 0003-3022
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 1996
    ZDB Id: 2016092-6
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    In: Immunity, Elsevier BV, Vol. 42, No. 1 ( 2015-01), p. 123-132
    Materialart: Online-Ressource
    ISSN: 1074-7613
    RVK:
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2015
    ZDB Id: 2001966-X
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Online-Ressource
    Online-Ressource
    American Association for Cancer Research (AACR) ; 2012
    In:  Cancer Research Vol. 72, No. 8_Supplement ( 2012-04-15), p. 3886-3886
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 8_Supplement ( 2012-04-15), p. 3886-3886
    Kurzfassung: The purpose of the present study was to develop DNA aptamers through a spontaneous cell-based SELEX method (systemic evolution of ligands by exponential enrichment) that specifically binding to cell surface proteins or biomarkers produced by primary cultured tumor endothelial cells (TECs). In solid tumors, new blood vessels are formed through an angiogenesis process, and this plays a critical role in cancer development as well as the development of metastasis. To combat angiogenesis, an appropriate diagnosis and understanding at the molecular level of different cancer types is now a high priority. Our initial study explored the use of the cell-based SELEX method, which has been applied in TECs to generate high affinity DNA aptamers. Our selected DNA aptamer AraHH001 bound specifically and with a high affinity to TECs in the nanomolar range but did not bind to normal skin endothelial cells (skin-ECs) and tumor parenchymal OSRC-II cells. The selected DNA aptamers also bounded to primary cultured human tumor endothelial cells (hTECs) isolated from a clinical patient with a renal carcinoma. Therefore, the development of specific DNA aptamers that bind to TECs is reported here for the first time. We conclude that such new DNA aptamers promise to hold great promise as targeted molecular probes that appear to play a major role in angiogenesis, drug delivery, identification of biomarker as well as in cancer therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3886. doi:1538-7445.AM2012-3886
    Materialart: Online-Ressource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Sprache: Englisch
    Verlag: American Association for Cancer Research (AACR)
    Publikationsdatum: 2012
    ZDB Id: 2036785-5
    ZDB Id: 1432-1
    ZDB Id: 410466-3
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 1990
    In:  Anesthesiology Vol. 72, No. 5 ( 1990-05-01), p. 865-873
    In: Anesthesiology, Ovid Technologies (Wolters Kluwer Health), Vol. 72, No. 5 ( 1990-05-01), p. 865-873
    Materialart: Online-Ressource
    ISSN: 0003-3022
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 1990
    ZDB Id: 2016092-6
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 5
    Online-Ressource
    Online-Ressource
    American Society for Microbiology ; 2013
    In:  Infection and Immunity Vol. 81, No. 1 ( 2013-01), p. 311-316
    In: Infection and Immunity, American Society for Microbiology, Vol. 81, No. 1 ( 2013-01), p. 311-316
    Kurzfassung: Human CD1b molecules contain a maze of hydrophobic pockets and a tunnel capable of accommodating the unusually long, branched acyl chain of mycolic acids, an essential fatty acid component of the cell wall of mycobacteria. It has been accepted that CD1b-bound mycolic acids constitute a scaffold for mycolate-containing (glyco)lipids stimulating CD1b-restricted T cells. Remarkable homology in amino acid sequence is observed between human and monkey CD1b molecules, and indeed, monkey CD1b molecules are able to bind glucose monomycolate (GMM), a glucosylated species of mycolic acids, and present it to specific human T cells in vitro . Nevertheless, we found, unexpectedly, that Mycobacterium bovis bacillus Calmette-Guerin (BCG)-vaccinated monkeys exhibited GMM-specific T cell responses that were restricted by CD1c rather than CD1b molecules. GMM-specific, CD1c-restricted T cells were detected in the circulation of all 4 rhesus macaque monkeys tested after but not before vaccination with BCG. The circulating GMM-specific T cells were detected broadly in both CD4 + and CD8 + cell populations, and upon antigenic stimulation, a majority of the GMM-specific T cells produced both gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α), two major host protective cytokines functioning against infection with mycobacteria. Furthermore, the GMM-specific T cells were able to extravasate and approach the site of infection where CD1c + cells accumulated. These observations indicate a previously inconceivable role for primate CD1c molecules in eliciting T cell responses to mycolate-containing antigens.
    Materialart: Online-Ressource
    ISSN: 0019-9567 , 1098-5522
    RVK:
    Sprache: Englisch
    Verlag: American Society for Microbiology
    Publikationsdatum: 2013
    ZDB Id: 1483247-1
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 6
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 1997
    In:  Anesthesiology Vol. 87, No. 4 ( 1997-10-01), p. 884-899
    In: Anesthesiology, Ovid Technologies (Wolters Kluwer Health), Vol. 87, No. 4 ( 1997-10-01), p. 884-899
    Kurzfassung: Understanding the influence of physiological variables on thiopental pharmacokinetics would enhance the scientific basis for the clinical usage of this anesthetic. Methods A physiological pharmacokinetic model for thiopental previously developed in rats was scaled to humans by substituting human values for tissue blood flows, tissue masses, and elimination clearance in place of respective rat values. The model was validated with published serum concentration data from 64 subjects. The model was simulated after intravenous thiopental administration, 250 mg, over 1 min, to predict arterial plasma concentrations under conditions of different cardiac outputs, degrees of obesity, gender, or age. Results The human pharmacokinetic model is characterized by a steady state volume of distribution of 2.2 l/kg, an elimination clearance of 0.22 l/min, and a terminal half-life of 9 h. Measured thiopental concentrations are predicted with an accuracy of 6 +/- 37% (SD). Greater peak arterial concentrations are predicted in subjects with a low versus a high cardiac output (3.1 and 9.4 l/min), and in subjects who are lean versus obese (56 and 135 kg). Acutely, obesity influences concentrations because it affects cardiac output. Prolonged changes are due to differences in fat mass. Changes with gender and age are relatively minor. Conclusions The physiological pharmacokinetic model developed in rats predicts thiopental pharmacokinetics in humans. Differences in basal cardiac output may explain much of the variability in early thiopental disposition between subjects.
    Materialart: Online-Ressource
    ISSN: 0003-3022
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 1997
    ZDB Id: 2016092-6
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 7
    In: Journal of Immunological Methods, Elsevier BV, Vol. 357, No. 1-2 ( 2010-5), p. 43-50
    Materialart: Online-Ressource
    ISSN: 0022-1759
    RVK:
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2010
    ZDB Id: 1500495-8
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 8
    Online-Ressource
    Online-Ressource
    American Association for Cancer Research (AACR) ; 2015
    In:  Cancer Research Vol. 75, No. 13_Supplement ( 2015-07-01), p. B64-B64
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 13_Supplement ( 2015-07-01), p. B64-B64
    Kurzfassung: Cellular uptake process of cationic peptide modified liposome is still obscured in perspective of cell biology. The mechanisms responsible for the internalization of oligo arginine, oligo-lysine, TAT and other arginine or lysine enriched peptide have focused on macropinocytosis. No information was reported about the uptake process of repeated cationic arginine or lysine (hydrophilic moiety) followed by leucine or alanine (hydrophobic moiety) with lipid bilayer based DNA nanocargoes. Here we orchestrated the concept of repeated lys-ala-leu-ala (KALA) peptide modified DNA-protamine-lipid nanoparticle, proclaimed a promising transfection activity in dendritic cell, following GPCR mediated endocytosis. Chemical inhibitors studies of chlorpromazine, Fillipin, and Amiloride did not support the concept of macropinocytosis, clathrin mediated endocytosis and cavaeola mediated endocytosis. Cetirizine hydrochloride, a GPCR blocker shut down the KALA mediated transgene expression. Confocal studies showed no liposomal uptake in KALA modification rather than R8 modification, which implies to receptor mediated endocytosis and thereby transgene expression. Low concentration of KALA pretreatment allowed a R8 MEND (usually non-expressed) to that of the same expression of KALA MEND and vice versa of high concentration KALA pretreatment. In a nut-shell performance of KALA ensured an engulfment of GPCR based endocytosis as well as GPCR activation thereby, that outcomes a boom transgene expression in dendritic cell. Citation Format: Sharif Mohammad Shaheen, Hidetaka Akita, Hideyoshi Harashima. A Lys-Ala-Leu-Ala (KALA) repeated peptide modification in DNA nanoparticles of DOPE/CHEMS, follows GPCR mediated transgene expression in dendritic cell. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr B64.
    Materialart: Online-Ressource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Sprache: Englisch
    Verlag: American Association for Cancer Research (AACR)
    Publikationsdatum: 2015
    ZDB Id: 2036785-5
    ZDB Id: 1432-1
    ZDB Id: 410466-3
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 9
    In: Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 96, No. 5 ( 2013-09-15), p. 445-453
    Materialart: Online-Ressource
    ISSN: 0041-1337
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2013
    ZDB Id: 2035395-9
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 10
    Online-Ressource
    Online-Ressource
    American Association for Cancer Research (AACR) ; 2009
    In:  Cancer Research Vol. 69, No. 23_Supplement ( 2009-12-01), p. C66-C66
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 69, No. 23_Supplement ( 2009-12-01), p. C66-C66
    Kurzfassung: Recent studies have reported that control of nuclear decondensation at specific nuclear subdomains (i.e. euchromatin) is highly desired for the efficient transfection efficiency. Here, we have established a novel technology for the imaging of nuclear condensation/decondensation status in the nuclear subdomains (i.e. heterochromatin and euchromatin) by based on the three key technologies. One is imaging of fluorescence resonance energy transfer (FRET) between quantum dots (QDs)-labeled plasmid DNA (pDNA) as a donor, and acceptor-labeled polycation, which can monitor a specific molecular interactions at the nanometre scale. The second technology is a multilayered lipid envelope-type nanoparticle, which we refer to as a Tetra-lamellar Multi-functional Envelope-type Nano Device (T-MEND). The critical structural elements of the T-MEND are a DNA—polycation condensed core coated with two nuclear membrane-fusogenic inner envelopes and two endosome-fusogenic outer envelopes, which are designed for nuclear delivery via a stepwise fusion. It is required to evaluate the nuclear dispositions in relation to the transgene expression, to avoid a situation that intracellular trafficking processes rate-limit transfection activity. The last one is confocal image-assisted 3-dimensionally integrated quantification (CIDIQ) method. In this method, fluorophore-labeled pDNA was transfected in HeLa cell line, and then intracellular distribution was distinguished by staining organelle. Z-series of confocal images were captured by confocal laser scanning microscopy (CLSM), and thereafter, pDNA was quantified based on the pixel area of the signals derived from the fluorophore on pDNA in nuclear subdomains (heterochromatin and euchromatin). As a model of the analysis, QD-labeled DNA was condensed with reductive environment-dependently cleavable polyrotaxane (DMAE-ss-PRX), an artificial condenser, and encapsulated in T-MEND. As a result, transfection activity depends on the number of cationic DMAE of cyclodextrin (α-CD), in conjunction with a drastic change in decondensation efficiency in euchromatin region. These data collectively indicate that this imaging technology is highly advantageous to clarify the dynamics of plasmid DNA in post-nuclear delivery process of cancer cells. Citation Information: Cancer Res 2009;69(23 Suppl):C66.
    Materialart: Online-Ressource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Sprache: Englisch
    Verlag: American Association for Cancer Research (AACR)
    Publikationsdatum: 2009
    ZDB Id: 2036785-5
    ZDB Id: 1432-1
    ZDB Id: 410466-3
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...